| European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of … A Guarino, S Ashkenazi, D Gendrel, AL Vecchio, R Shamir, H Szajewska Journal of pediatric gastroenterology and nutrition 59 (1), 132-152, 2014 | 983 | 2014 |
| European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of … A Guarino, F Albano, S Ashkenazi, D Gendrel, JH Hoekstra, R Shamir, ... Journal of pediatric gastroenterology and nutrition 46 (5), 619-621, 2008 | 674 | 2008 |
| Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections S Ashkenazi, A Vertruyen, J Arístegui, S Esposito, DD McKeith, T Klemola, ... The Pediatric infectious disease journal 25 (10), 870-879, 2006 | 369 | 2006 |
| Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults D Cohen, S Ashkenazi, MS Green, M Gdalevich, G Robin, R Slepon, ... The Lancet 349 (9046), 155-159, 1997 | 332 | 1997 |
| Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells N Firon, S Ashkenazi, D Mirelman, I Ofek, N Sharon Infection and immunity 55 (2), 472-476, 1987 | 299 | 1987 |
| Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries Y Hsia, BR Lee, A Versporten, Y Yang, J Bielicki, C Jackson, J Newland, ... The Lancet Global Health 7 (7), e861-e871, 2019 | 291 | 2019 |
| Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. JN Walterspiel, S Ashkenazi, AL Morrow, TG Cleary Infection 20 (1), 25-29, 1992 | 271 | 1992 |
| Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins EL Lopez, M Diaz, S Grinstein, S Devoto, F Mendilaharzu, BE Murray, ... Journal of Infectious Diseases 160 (3), 469-475, 1989 | 257 | 1989 |
| IN ISRAEL D Cohen, S Ashkenazi, M Green, M Gdalevich, M Yavzori, D Taylor, ... NOVEL STRATEGIES IN THE DESIGN AND PRODUCTION OF VACCINES, 159, 1990 | 255 | 1990 |
| Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome Z Shimoni, S Pitlik, L Leibovici, Z Samra, H Konigsberger, M Drucker, ... Clinical infectious diseases 28 (4), 822-827, 1999 | 232 | 1999 |
| Nosocomial infections after cardiac surgery in infants and children: incidence and risk factors I Levy, B Ovadia, E Erez, S Rinat, S Ashkenazi, E Birk, H Konisberger, ... Journal of Hospital Infection 53 (2), 111-116, 2003 | 228 | 2003 |
| Growing antimicrobial resistance of Shigella isolates S Ashkenazi, I Levy, V Kazaronovski, Z Samra Journal of Antimicrobial Chemotherapy 51 (2), 427-429, 2003 | 216 | 2003 |
| Long-term survival following bacteremia or fungemia L Leibovici, Z Samra, H Konigsberger, M Drucker, S Ashkenazi, SD Pitlik Jama 274 (10), 807-812, 1995 | 209 | 1995 |
| Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a … DN Taylor, AC Trofa, J Sadoff, C Chu, D Bryla, J Shiloach, D Cohen, ... Infection and immunity 61 (9), 3678-3687, 1993 | 209 | 1993 |
| Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care T Vesikari, DM Fleming, JF Aristegui, A Vertruyen, S Ashkenazi, ... Pediatrics 118 (6), 2298-2312, 2006 | 195 | 2006 |
| Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study I Levy, J Katz, E Solter, Z Samra, B Vidne, E Birk, S Ashkenazi, O Dagan The Pediatric infectious disease journal 24 (8), 676-679, 2005 | 192 | 2005 |
| Safety and Immunogenicity of ImprovedShigella O-Specific Polysaccharide-Protein Conjugate Vaccines in Adults in Israel JH Passwell, E Harlev, S Ashkenazi, C Chu, D Miron, R Ramon, N Farzan, ... Infection and immunity 69 (3), 1351-1357, 2001 | 175 | 2001 |
| Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children JH Passwell, S Ashkenazi, Y Banet-Levi, R Ramon-Saraf, N Farzam, ... Vaccine 28 (10), 2231-2235, 2010 | 168 | 2010 |
| Shigella infections in children: new insights S Ashkenazi Seminars in pediatric infectious diseases 15 (4), 246-252, 2004 | 161 | 2004 |
| Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody R Dagan, J Amir, A Mijalovsky, I Kalmanovitch, A Bar-Yochai, S Thoelen, ... The Pediatric infectious disease journal 19 (11), 1045-1052, 2000 | 157 | 2000 |